Overview
About AROA™ | Clinical
This page showcases clinical research, product evidence and outcomes behind our third generation AROA ECM technology, demonstrating how we are unlocking regenerative healing for everybody.
Built on our proprietary AROA ECM platform, derived from ovine (sheep) forestomach and sourced in New Zealand, our third generation bioscaffold product portfolio spans four product families for chronic wounds, hernia repair, soft-tissue reconstruction and breast reconstruction.
Headquartered in Auckland, New Zealand, with distribution, sales and customer support in the United States, AROA™ develops soft-tissue regeneration solutions that improve the rate and quality of healing in complex wounds and soft tissue reconstruction procedures.
Built on our proprietary AROA ECM platform, derived from ovine (sheep) forestomach and sourced in New Zealand, our third generation bioscaffold product portfolio spans four product families for chronic wounds, hernia repair, soft-tissue reconstruction and breast reconstruction.
Headquartered in Auckland, New Zealand, with distribution, sales and customer support in the United States, AROA™ develops soft-tissue regeneration solutions that improve the rate and quality of healing in complex wounds and soft tissue reconstruction procedures.